BELVIN MARCIA

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$42,807.08

Insider Activity of BELVIN MARCIA

According to the SEC Form 4 filings, BELVIN MARCIA, being in a position of

  1. SVP, Chief Scientific Officer at CytomX Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21053 shares for $37,451,
    over all time since 2023-09-22, has bought 0 shares, and sold 25172 shares for $42,807.

The largest sale of all time was on 2024-03-19 and amounted to 12795 shares of CytomX Therapeutics, Inc. for $26,684.

Biography of BELVIN MARCIA

No biography is available at this moment.

2024-08-20SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
4,181
0.0053%
$1.23$5,139-4.03%
2024-03-19SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
12,795
0.0181%
$2.09$26,684-28.9%
2023-12-20SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
4,077
0.0063%
$1.38$5,628+19.74%
2023-09-22SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
4,119
0.0063%
$1.30$5,356+14.06%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.